BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 7734464)

  • 1. The Matrix model of outpatient stimulant abuse treatment: evidence of efficacy.
    Shoptaw S; Rawson RA; McCann MJ; Obert JL
    J Addict Dis; 1994; 13(4):129-41. PubMed ID: 7734464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Imipramine for the treatment of cocaine and methamphetamine dependence.
    Galloway GP; Newmeyer J; Knapp T; Stalcup SA; Smith D
    J Addict Dis; 1994; 13(4):201-16. PubMed ID: 7734470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of lisuride on mood and sleep during acute withdrawal in stimulant abusers: a preliminary report.
    Gillin JC; Pulvirenti L; Withers N; Golshan S; Koob G
    Biol Psychiatry; 1994 Jun; 35(11):843-9. PubMed ID: 8054406
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
    Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
    Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of desipramine or carbamazepine on patient retention in outpatient cocaine treatment: preliminary findings.
    Campbell JL; Thomas HM; Gabrielli W; Liskow BI; Powell BJ
    J Addict Dis; 1994; 13(4):191-9. PubMed ID: 7734469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gender differences in cocaine use and treatment response.
    Kosten TA; Gawin FH; Kosten TR; Rounsaville BJ
    J Subst Abuse Treat; 1993; 10(1):63-6. PubMed ID: 8450576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desipramine facilitation of initial cocaine abstinence.
    Gawin FH; Kleber HD; Byck R; Rounsaville BJ; Kosten TR; Jatlow PI; Morgan C
    Arch Gen Psychiatry; 1989 Feb; 46(2):117-21. PubMed ID: 2492422
    [TBL] [Abstract][Full Text] [Related]  

  • 8. One-year follow-up after multimodal inpatient treatment for cocaine and methamphetamine dependencies.
    Frawley PJ; Smith JW
    J Subst Abuse Treat; 1992; 9(4):271-86. PubMed ID: 1336066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year follow-up of psychotherapy and pharmacotherapy for cocaine dependence. Delayed emergence of psychotherapy effects.
    Carroll KM; Rounsaville BJ; Nich C; Gordon LT; Wirtz PW; Gawin F
    Arch Gen Psychiatry; 1994 Dec; 51(12):989-97. PubMed ID: 7979888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug withdrawal therapies].
    Ladewig D; Petitjean S
    Internist (Berl); 1999 Jun; 40(6):624-7. PubMed ID: 10420316
    [No Abstract]   [Full Text] [Related]  

  • 11. Using cue reactivity to screen medications for cocaine abuse: a test of amantadine hydrochloride.
    Robbins SJ; Ehrman RN; Childress AR; O'Brien CP
    Addict Behav; 1992; 17(5):491-9. PubMed ID: 1332435
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinically relevant characteristics associated with early treatment drug use versus abstinence.
    Cochran G; Stitzer M; Nunes EV; Hu MC; Campbell A
    Addict Sci Clin Pract; 2014 Apr; 9(1):6. PubMed ID: 24708748
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subjective reports of withdrawal among cocaine users: recommendations for DSM-IV.
    Cottler LB; Shillington AM; Compton WM; Mager D; Spitznagel EL
    Drug Alcohol Depend; 1993 Sep; 33(2):97-104. PubMed ID: 8261885
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Desipramine, amantadine, or fluoxetine in buprenorphine-maintained cocaine users.
    Oliveto A; Kosten TR; Schottenfeld R; Falcioni J; Ziedonis D
    J Subst Abuse Treat; 1995; 12(6):423-8. PubMed ID: 8749726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amantadine may facilitate detoxification of cocaine addicts.
    Alterman AI; Droba M; Antelo RE; Cornish JW; Sweeney KK; Parikh GA; O'Brien CP
    Drug Alcohol Depend; 1992 Oct; 31(1):19-29. PubMed ID: 1330470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial treatments for cocaine abuse. 12-month treatment outcomes.
    Hoffman JA; Caudill BD; Koman JJ; Luckey JW; Flynn PM; Mayo DW
    J Subst Abuse Treat; 1996; 13(1):3-11. PubMed ID: 8699540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of amantadine and desipramine combined with psychotherapy for treatment of cocaine dependence.
    Weddington WW; Brown BS; Haertzen CA; Hess JM; Mahaffey JR; Kolar AF; Jaffe JH
    Am J Drug Alcohol Abuse; 1991 Jun; 17(2):137-52. PubMed ID: 1862788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment outcome of 600 chemically dependent patients treated in a multimodal inpatient program including aversion therapy and pentothal interviews.
    Smith JW; Frawley PJ
    J Subst Abuse Treat; 1993; 10(4):359-69. PubMed ID: 8105103
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
    Kampman KM; Dackis C; Lynch KG; Pettinati H; Tirado C; Gariti P; Sparkman T; Atzram M; O'Brien CP
    Drug Alcohol Depend; 2006 Nov; 85(2):129-37. PubMed ID: 16697124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotherapy and pharmacotherapy for ambulatory cocaine abusers.
    Carroll KM; Rounsaville BJ; Gordon LT; Nich C; Jatlow P; Bisighini RM; Gawin FH
    Arch Gen Psychiatry; 1994 Mar; 51(3):177-87. PubMed ID: 8122955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.